<!DOCTYPE html>
<html>
  <head>
    <title>COPD</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/respiratory/">respiratory</a></li>
      <li class="active">COPD</li>
  </ol>

  <div class="page-header">
 
    <h1>COPD</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>COPD</strong></a>
          <div class="toc">
<ul>
<li><a href="#definition">definition</a></li>
<li><a href="#diagnosis">Diagnosis</a><ul>
<li><a href="#spirometry">spirometry</a></li>
</ul>
</li>
<li><a href="#differential-diagnosis">differential diagnosis:</a></li>
<li><a href="#causes">Causes</a></li>
<li><a href="#assessment">Assessment</a><ul>
<li><a href="#symptoms">symptoms</a></li>
<li><a href="#degree-of-airflow-limitation">Degree of airflow limitation</a></li>
<li><a href="#risk-of-exacerbations">Risk of exacerbations</a></li>
<li><a href="#assess-comorbidities">Assess comorbidities</a></li>
</ul>
</li>
<li><a href="#combined-assessment">Combined assessment</a></li>
<li><a href="#management">management</a><ul>
<li><a href="#smoking-cessation">smoking cessation</a></li>
<li><a href="#smoking-prevention">smoking prevention</a></li>
<li><a href="#occupational-exposure">occupational exposure</a></li>
<li><a href="#indoor-and-outdoor-air-pollution">indoor and outdoor air pollution</a></li>
<li><a href="#physical-exercise">Physical exercise</a></li>
<li><a href="#pharmacological">Pharmacological</a><ul>
<li><a href="#bronchodilators">Bronchodilators</a></li>
<li><a href="#laba">LABA</a></li>
<li><a href="#inhaled-corticosteroids">Inhaled corticosteroids</a></li>
<li><a href="#combination-inhaled-corticosteroidbronchodilator-therapy">Combination inhaled corticosteroid/bronchodilator therapy</a></li>
<li><a href="#oral-corticosteroids">Oral corticosteroids</a></li>
<li><a href="#phophodiesterase-4-inhibitiors">Phophodiesterase-4 inhibitiors</a></li>
<li><a href="#methylxanthines-theophylline">Methylxanthines (theophylline)</a></li>
<li><a href="#other">Other</a></li>
</ul>
</li>
<li><a href="#rehabilitation">Rehabilitation</a></li>
<li><a href="#o2">O2</a></li>
<li><a href="#surgical">Surgical</a></li>
</ul>
</li>
<li><a href="#exacerbations">Exacerbations</a><ul>
<li><a href="#assessment_1">assessment</a></li>
<li><a href="#treatment">Treatment</a></li>
</ul>
</li>
<li><a href="#copd-and-comorbdiities">COPD and comorbdiities</a><ul>
<li><a href="#cardiovascular-disease">Cardiovascular disease</a></li>
<li><a href="#osteoporosis">Osteoporosis</a></li>
<li><a href="#anxietydepression">Anxiety/depression</a></li>
<li><a href="#lung-cancer">Lung cancer</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <h3 id="definition">definition</h3>
<blockquote>
<p>persistent airflow limitation that is usually proressive and associated with enhanced chronic inflammatory response in the airways and lung to noxious particles or gases</p>
<p>not fully reversible</p>
<p>doesn’t change over several months</p>
</blockquote>
<ul>
<li>
<p>symptoms:</p>
<ul>
<li>
<p>dyspnoea</p>
</li>
<li>
<p>chronic cough</p>
</li>
<li>
<p>chronic sputum production</p>
</li>
</ul>
</li>
<li>
<p>epsidoes of acute worsening (exacerbations) often ovvur</p>
</li>
</ul>
<h3 id="diagnosis">Diagnosis</h3>
<ul>
<li>
<p>Consider and perform spirometry if ≥40yo:</p>
<ul>
<li>
<p>dyspnoea that is</p>
<ul>
<li>
<p>progressive</p>
</li>
<li>
<p>characteristically worse with exercise</p>
</li>
<li>
<p>persistent</p>
</li>
</ul>
</li>
<li>
<p>Chronic cough</p>
</li>
<li>
<p>Chronic sputum produciton</p>
</li>
<li>
<p>exposre to risk factors</p>
</li>
<li>
<p>family history of copd</p>
</li>
</ul>
</li>
</ul>
<h4 id="spirometry">spirometry</h4>
<ul>
<li>FEV1/FVC \&lt; 0.70 - confirms presence of persistent airflow limitation</li>
</ul>
<h3 id="differential-diagnosis">differential diagnosis:</h3>
<ul>
<li>
<p>COPD</p>
<ul>
<li>
<p>onset mid life</p>
</li>
<li>
<p>slowly progressive</p>
</li>
<li>
<p>history of smoking/exposure</p>
</li>
</ul>
</li>
<li>
<p>Asthma</p>
<ul>
<li>
<p>onset early in life</p>
</li>
<li>
<p>symptoms vary widely day - day</p>
</li>
<li>
<p>worse @ night/early morning</p>
</li>
<li>
<p>atopy</p>
</li>
<li>
<p>fhx astham</p>
</li>
</ul>
</li>
<li>
<p>CHF</p>
<ul>
<li>
<p>volume restriction compared to obstructive</p>
</li>
<li>
<p>CR</p>
</li>
</ul>
</li>
<li>
<p>Bronchiectasis</p>
<ul>
<li>
<p>large volumes of purulent sputum</p>
</li>
<li>
<p>cxr</p>
</li>
<li>
<p>associated with bacterial infection</p>
</li>
</ul>
</li>
<li>
<p>Tb</p>
<ul>
<li>
<p>onset all ages</p>
</li>
<li>
<p>cxr</p>
</li>
<li>
<p>micro</p>
</li>
</ul>
</li>
<li>
<p>Obliterative bronchiolitis</p>
<ul>
<li>
<p>younger</p>
</li>
<li>
<p>non smokers</p>
</li>
<li>
<p>histoyr of RA, acute fume exposure</p>
</li>
<li>
<p>seen after lung/bone marrow transplantaion</p>
</li>
</ul>
</li>
<li>
<p>Diffuse panbronchiolitis</p>
<ul>
<li>
<p>asian</p>
</li>
<li>
<p>male and nonsmoker</p>
</li>
<li>
<p>chronic sinusitis</p>
</li>
<li>
<p>cxr/CT - small cetnrilobular nodular opacities and hyperinflation</p>
</li>
</ul>
</li>
</ul>
<h3 id="causes">Causes</h3>
<ul>
<li>
<p>tobacco</p>
</li>
<li>
<p>indoor air pollution</p>
<ul>
<li>biomass fuel used for cooking and heating</li>
</ul>
</li>
<li>
<p>occupational dusts and chemicals</p>
</li>
<li>
<p>outdoor air pollution</p>
</li>
<li>
<p>any factors that affects lung growth during gestation and childhood</p>
<ul>
<li>
<p>Low birth weight</p>
</li>
<li>
<p>respiratory infections</p>
</li>
</ul>
</li>
</ul>
<h3 id="assessment">Assessment</h3>
<h4 id="symptoms">symptoms</h4>
<ul>
<li>
<p>validated questionairres</p>
<ul>
<li>
<p>CAT</p>
</li>
<li>
<p>Clinical copd questionairre</p>
</li>
<li>
<p>mMRC</p>
</li>
</ul>
</li>
</ul>
<h4 id="degree-of-airflow-limitation">Degree of airflow limitation</h4>
<ul>
<li>
<p>GOLD 1</p>
<ul>
<li>
<p>mild</p>
</li>
<li>
<p>fev1 ≥ 80% predicted</p>
</li>
</ul>
</li>
<li>
<p>GOLD 2</p>
<ul>
<li>
<p>moderate</p>
</li>
<li>
<p>50% ≤ FEV1 ≤ 80%</p>
</li>
</ul>
</li>
<li>
<p>GOLD 3</p>
<ul>
<li>
<p>severe</p>
</li>
<li>
<p>30% ≤ FEVI ≤ 50%</p>
</li>
</ul>
</li>
<li>
<p>GOLD 4</p>
<ul>
<li>
<p>Very severe</p>
</li>
<li>
<p>FEV1 \&lt;30%</p>
</li>
</ul>
</li>
</ul>
<h4 id="risk-of-exacerbations">Risk of exacerbations</h4>
<ul>
<li>
<p>acute event characterised by worsening of patient’s respiratory symptoms</p>
</li>
<li>
<p>beyond normal day-day variations</p>
</li>
<li>
<p>leads to a change in medication</p>
</li>
<li>
<p>best predictor = frequent exacernation (≥ 2/year)</p>
</li>
<li>
<p>history of previous treated events</p>
</li>
<li>
<p>hospitalisation for copd exac. is associated with poor prognosis </p>
<ul>
<li>inc. risk of death</li>
</ul>
</li>
</ul>
<h4 id="assess-comorbidities">Assess comorbidities</h4>
<ul>
<li>
<p>CVS</p>
</li>
<li>
<p>osteoporosis</p>
</li>
<li>
<p>depresison/anxiety</p>
</li>
<li>
<p>skeletal muscle dysfunction</p>
</li>
<li>
<p>metabolic sydnrome</p>
</li>
<li>
<p>lung cancer</p>
</li>
</ul>
<h3 id="combined-assessment">Combined assessment</h3>
<p>| <em>GOLD</em>    | | | exacerbations |</p>
<p>| :---- | :----: | :----\: | :-----: |</p>
<p>| <strong>4</strong>:  <em>\&lt;30%</em> | <strong>C</strong> | <strong>D</strong> | ≥ 2 |</p>
<p>| <strong>3</strong>:  <em>30% ≤ FEV1 ≤ 50%</em>| <strong>ICS + LABA or LAAC</strong> | <strong>ICS + LABA and/or LAMA</strong> | | </p>
<p>| --- ||  - |</p>
<p>|  <strong>2</strong>: <em>50% ≤ FEV1 ≤ 80%</em> | <strong>A</strong> | <strong>B</strong> | 1 + no hospital |</p>
<p>| <strong>1</strong> : <em>FEV1 > 80%</em> |<strong> SABA or SAMA</strong> | <strong>LABA and/or LAMA</strong> | 0 |</p>
<p>|  --- || - |</p>
<p>|  | mMRC 0-1 | mMRC ≥ 2 |  |</p>
<p>| <strong><em>symptoms</em></strong> ||||</p>
<h3 id="management">management</h3>
<h4 id="smoking-cessation">smoking cessation</h4>
<ul>
<li>
<p>brief (3-minute) period of counseling to urge = quit rates 5-10%</p>
</li>
<li>
<p>NRT</p>
</li>
<li>
<p>pharmacotherapy</p>
</li>
<li>
<p>most effective treatment for patients wtih COPD</p>
</li>
<li>
<p>only intervention to impact mortality</p>
</li>
<li>
<p>intensive counselling plus pharmacotherapy = most cost effective intervention</p>
</li>
</ul>
<h4 id="smoking-prevention">smoking prevention</h4>
<h4 id="occupational-exposure">occupational exposure</h4>
<ul>
<li>primary prevention</li>
</ul>
<h4 id="indoor-and-outdoor-air-pollution">indoor and outdoor air pollution</h4>
<h4 id="physical-exercise">Physical exercise</h4>
<ul>
<li>
<p>all COPD patients benefit from regular physical activity</p>
</li>
<li>
<p>encouraged to remain active</p>
</li>
</ul>
<h4 id="pharmacological">Pharmacological</h4>
<ul>
<li>
<p>reduce symptoms</p>
</li>
<li>
<p>reduce frequency and severity</p>
</li>
<li>
<p>improve health status</p>
</li>
<li>
<p>improve exercise tolerance</p>
</li>
<li>
<p>needs to be patient-specific</p>
</li>
</ul>
<h5 id="bronchodilators">Bronchodilators</h5>
<ul>
<li>
<p>inhaled therapy preferred</p>
</li>
<li>
<p>choice depends on availability</p>
</li>
<li>
<p>prn/regular</p>
</li>
<li>
<p>LA convienient</p>
<ul>
<li>more effective maintained symptom relief</li>
</ul>
</li>
<li>
<p>tiotropium improves effectivelness of pulmonary rehab</p>
</li>
<li>
<p>combining may improve efficacy and decrease risk of side effects compared to increasing dose of single bronchodilator</p>
</li>
</ul>
<h5 id="laba">LABA</h5>
<ul>
<li>
<p>improve lung function and health relate QoL, decrease dyspnoea, symptom scores, need for rescue and exacerabtions</p>
</li>
<li></li>
</ul>
<h5 id="inhaled-corticosteroids">Inhaled corticosteroids</h5>
<ul>
<li>
<p>if fev1 ≤ 60% predicted</p>
</li>
<li>
<p>regular inhaled corticosteroids improves:</p>
<ul>
<li>
<p>symptoms</p>
</li>
<li>
<p>lung function</p>
</li>
<li>
<p>QoL</p>
</li>
<li>
<p>decrease frequency of exacerbations</p>
</li>
</ul>
</li>
<li>
<p>associated with increase risk of pneumonia</p>
</li>
<li>
<p>withdrawal may lead to exacerbations</p>
</li>
<li>
<p>long-term monotherapy not recommended</p>
</li>
</ul>
<h5 id="combination-inhaled-corticosteroidbronchodilator-therapy">Combination inhaled corticosteroid/bronchodilator therapy</h5>
<ul>
<li>
<p>(LABA)</p>
</li>
<li>
<p>more effective than either individual componenet:</p>
<ul>
<li>
<p>improves lung function</p>
</li>
<li>
<p>health status</p>
</li>
</ul>
</li>
<li>
<p>decrease exacerbations in patinets with moderate - very severe COPD</p>
</li>
<li>
<p>combination associated increase risk of pneumonia</p>
</li>
<li>
<p>add combo to tiotropium = additional benefit</p>
</li>
</ul>
<h5 id="oral-corticosteroids">Oral corticosteroids</h5>
<ul>
<li>long term treatment not recommended</li>
</ul>
<h5 id="phophodiesterase-4-inhibitiors">Phophodiesterase-4 inhibitiors</h5>
<ul>
<li>
<p>GOLD3/4 with exacerbations</p>
<ul>
<li>roflumilast decrease exacerbations</li>
</ul>
</li>
</ul>
<h5 id="methylxanthines-theophylline">Methylxanthines (theophylline)</h5>
<ul>
<li>
<p>less effective</p>
</li>
<li>
<p>less well tolerated than LABA</p>
</li>
<li>
<p>modest bronchodilator effect</p>
</li>
<li>
<p>addition of theophylline to salmeterol produces increase FEV1 and relief of SOB compared to salmerterol alnoe</p>
</li>
</ul>
<h5 id="other">Other</h5>
<ul>
<li>
<p>Vaccines</p>
<ul>
<li>
<p>pneumococcal ≥65yo</p>
<ul>
<li>
<p>reduce CAP in \&lt;65yo with FEV1 \&lt; 40% predict</p>
</li>
<li>
<p>BMJ learning = “all patients”</p>
</li>
</ul>
</li>
<li>
<p>influenza </p>
</li>
</ul>
</li>
<li>
<p>Abx</p>
<ul>
<li>not recommended except rx of infectious exacerbations</li>
</ul>
</li>
</ul>
<h4 id="rehabilitation">Rehabilitation</h4>
<ul>
<li>
<p>all stages of disease benefit from exercise training programs</p>
</li>
<li>
<p>improvements in:</p>
<ul>
<li>
<p>exercise tolerance</p>
</li>
<li>
<p>symptoms of dyspnoea </p>
</li>
<li>
<p>fatigue</p>
</li>
</ul>
</li>
<li>
<p>sustained even after a simgle pulmonary rhabiliation program</p>
</li>
<li>
<p>minimum length = 6/52</p>
</li>
</ul>
<h4 id="o2">O2</h4>
<ul>
<li>
<p>>15hrs /day</p>
</li>
<li>
<p>increase survival with severe, resting hypoxaemia</p>
</li>
<li>
<p>LTOT:</p>
<ul>
<li>
<p>paO2 \&lt; 7.3kPA (55mmHg) or SaO2 ≤ 88% wiht or wihtout hypercapniea</p>
<ul>
<li>twice over 3w period</li>
</ul>
</li>
<li>
<p>paO2 between 7.3 and 8 (60mmHg) or spo2 ≤ 88% if evidence of:</p>
<ul>
<li>
<p>pulmonary hypertension</p>
</li>
<li>
<p>periperhal oedema</p>
<ul>
<li>suggesting CHF</li>
</ul>
</li>
<li>
<p>polycythemia</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="surgical">Surgical</h4>
<ul>
<li>
<p>lung volume reduction surgery</p>
</li>
<li>
<p>upper-lobe predominant emphysema</p>
</li>
</ul>
<h3 id="exacerbations">Exacerbations</h3>
<h4 id="assessment_1">assessment</h4>
<ul>
<li>
<p>CXR</p>
</li>
<li>
<p>ecg</p>
</li>
<li>
<p>(ABG)</p>
</li>
<li>
<p>FBC</p>
</li>
<li>
<p>purulent sputum</p>
</li>
<li>
<p>biochemisty</p>
</li>
<li>
<p>spirometry not useful during exacerbation</p>
</li>
</ul>
<h4 id="treatment">Treatment</h4>
<ul>
<li>
<p>O2</p>
</li>
<li>
<p>Bronchodilators</p>
<ul>
<li>SABA +/- SAAC</li>
</ul>
</li>
<li>
<p>Systemic corticosteroids</p>
<ul>
<li>
<p>shorten recovery</p>
</li>
<li>
<p>improve lung function</p>
</li>
<li>
<p>reduce risks of:</p>
<ul>
<li>
<p>early relapse</p>
</li>
<li>
<p>treatment failure</p>
</li>
<li>
<p>length of hospital stay</p>
</li>
</ul>
</li>
<li>
<p>40mg od for 5 days</p>
</li>
</ul>
</li>
<li>
<p>Antibiotics</p>
<ul>
<li>
<p>all 3:</p>
<ul>
<li>
<p>increase dyspnoea</p>
</li>
<li>
<p>increase sputum production</p>
</li>
<li>
<p>increase sputum purulence</p>
</li>
</ul>
</li>
<li>
<p>or sputum purulence + 1 other</p>
</li>
<li>
<p>mechanical </p>
</li>
</ul>
</li>
<li>
<p>Indications for hospital admission</p>
<ul>
<li>
<p>intesntity of symptoms</p>
</li>
<li>
<p>severe underlying COPD</p>
</li>
<li>
<p>onset new phsyical signs</p>
</li>
<li>
<p>failure of exacerbation to respond to initial medical managmeent</p>
</li>
<li>
<p>serious comorbidities</p>
</li>
<li>
<p>frequent exacaerbations</p>
</li>
<li>
<p>older age</p>
</li>
<li>
<p>insufficient home supprot</p>
</li>
</ul>
</li>
</ul>
<h3 id="copd-and-comorbdiities">COPD and comorbdiities</h3>
<h4 id="cardiovascular-disease">Cardiovascular disease</h4>
<ul>
<li>cardioselective beta-blockers are not contraindicated in COPD</li>
</ul>
<h4 id="osteoporosis">Osteoporosis</h4>
<h4 id="anxietydepression">Anxiety/depression</h4>
<h4 id="lung-cancer">Lung cancer</h4>
<p>end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
